Target discovery and validation in pancreatic cancer.

Robert M. Beaty, Mads Gronborg, Jonathan R. Pollack, Anirban Maitra

Research output: Contribution to journalReview articlepeer-review

Abstract

Pancreatic cancer is a lethal disease and rational strategies for early detection and targeted therapies are urgently required to alleviate the dismal prognosis of this neoplasm. The use of global RNA and protein expression-profiling technologies, such as DNA microarrays, serial analysis of gene expression, and mass spectrometric analysis of proteins, have led to identification of cellular targets with considerable potential for clinical application and patient care. These studies underscore the importance of pursuing large-scale profiling of human cancers not only for furthering our understanding of the pathogenesis of these malignancies but also for developing strategies to improve patient outcomes.

Original languageEnglish (US)
Pages (from-to)57-89
Number of pages33
JournalMethods in molecular biology (Clifton, N.J.)
Volume360
StatePublished - 2007
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'Target discovery and validation in pancreatic cancer.'. Together they form a unique fingerprint.

Cite this